When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Drug delivery to the brain - Wikipedia

    en.wikipedia.org/wiki/Drug_delivery_to_the_brain

    A group from the University of Oxford led by Prof. Matthew Wood claims that exosomes can cross the blood–brain barrier and deliver siRNAs, antisense oligonucleotides, chemotherapeutic agents and proteins specifically to neurons after inject them systemically (in blood). Because these exosomes are able to cross the blood–brain barrier, this ...

  3. Dopamine - Wikipedia

    en.wikipedia.org/wiki/Dopamine

    Dopamine does not cross the blood–brain barrier, so its synthesis and functions in peripheral areas are to a large degree independent of its synthesis and functions in the brain. [26] A substantial amount of dopamine circulates in the bloodstream, but its functions there are not entirely clear. [27]

  4. Blood–brain barrier - Wikipedia

    en.wikipedia.org/wiki/Blood–brain_barrier

    The blood–brain barrier (BBB) is a highly selective semipermeable border of endothelial cells that regulates the transfer of solutes and chemicals between the circulatory system and the central nervous system, thus protecting the brain from harmful or unwanted substances in the blood. [1]

  5. Carbidopa/levodopa/entacapone - Wikipedia

    en.wikipedia.org/wiki/Carbidopa/levodopa/entacapone

    Levodopa is the immediate precursor to dopamine. Entacapone is a selective, reversible catechol-O-methyltransferase (COMT) inhibitor that prevents the degradation of levodopa. Entacapone does not cross the blood–brain barrier. Carbidopa is a peripheral aromatic L-amino acid decarboxylase (AADC) inhibitor. Carbidopa, which also does not cross ...

  6. Carbidopa - Wikipedia

    en.wikipedia.org/wiki/Carbidopa

    Carbidopa is most commonly used as a method to inhibit the activity of DOPA decarboxylase. This is an enzyme that breaks down L-DOPA in the periphery and converts it to dopamine. This results in the newly formed dopamine being unable to cross the blood–brain barrier and the effectiveness of L-DOPA treatments is greatly decreased. Carbidopa ...

  7. Aromatic L-amino acid decarboxylase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Aromatic_L-amino_acid_de...

    Peripherally selective DDCIs incapable of crossing the protective blood–brain barrier (BBB) are used in augmentation of L-DOPA (levodopa) in the treatment of Parkinson's disease (PD) to block the conversion of L-DOPA into dopamine outside the brain, for the purpose of reducing adverse side effects. [3]

  8. ‘I Did The Viral Dopamine Detox—Here’s Why I Won ... - AOL

    www.aol.com/lifestyle/did-viral-dopamine-detox...

    FWIW, dopamine production is a natural body process, so you can't *actually* detox from it, nor should you want to, says Dave Sulzer, PhD, a professor of psychiatry, neurology, and neurobiology at ...

  9. Catechol-O-methyltransferase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Catechol-O-methyltransfer...

    Entacapone and opicapone are peripherally selective inhibitors, unable to cross the blood–brain barrier (BBB), and hence do not inhibit COMT in the brain. Tolcapone also appears to be peripherally selective. [2] However, it has been found to cross the BBB to at least some degree and significantly inhibit COMT in the brain as well.